Michael T. Siekman
Michael Siekman counsels clients of all sizes in the biotechnology and pharmaceutical industries on a range of intellectual property matters, including patent prosecution and portfolio strategy, interferences, due diligence, licensing, invalidity and noninfringement opinions, enforcement options, and litigation.
- Prosecuted patent applications in areas such as gene therapy, protein expression, antibodies, and recombinant vaccines, as well as numerous traditional pharmaceutical technologies.
- Served as lead or backup counsel in numerous patent interferences in the biotech, pharmaceutical, electrical, and consumer product fields.
- Maximized market exclusivity for clients via interaction of patent law and food and drug law under Hatch-Waxman Act.
- Coordinated worldwide prosecution of patent applications, including European opposition proceedings.
- Obtained Patent Term Extensions and advised clients on Orange Book patent listing strategies for New Drug Applications.
- Participated in several Abbreviated New Drug Application (ANDA) patent litigations.
Before entering law school, Michael worked as a patent agent for a large IP law firm. While attending law school, he co-founded and served as Articles Editor for the Boston University Journal of Science & Technology.
American Intellectual Property Law Association
- Interference Committee
Boston Patent Law Association
- Interference Committee
Intellectual Property Owners Association
- Interference Committee
Michael received a National Science Foundation Research Experiences for Undergraduates Award while in college.
Michael has also been named one of the Massachusetts Super Lawyers’ “Rising Stars” in the field of intellectual property law.
Bates College, B.S., Biology
Boston University School of Law, J.D., IP Law Concentration
Massachusetts
District of Columbia
U.S. Patent and Trademark Office
U.S. Court of Appeals for the Federal Circuit
